Laborate Pharmaceuticals India Limited Vati Export Data — India (DGFT 2022–2026)

Name: Laborate Pharmaceuticals India Limited Vati Export Records India — #14 Exporter, 55 Shipments, $339.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vati

India Pharmaceutical Trade Intelligence

$26.3M427 Suppliers141 CountriesHS 30049011

ExportsIndia → UNITED STATES34.3%India → GERMANY13.0%

#1 Supplier: MICRO LABS #1 Buyer: AUROBINDO PHARMA

Laborate Pharmaceuticals India Limited — Vati Exporter #14 | $2.2M Trade Value | TransData Nexus | TransData Nexus

Laborate Pharmaceuticals India Limited — Vati Exporter Profile

Indian Pharmaceutical Exporter · #14 for Vati · $2.2M export value · DGFT Verified

Laborate Pharmaceuticals India Limited is the #14 Indian exporter of Vati with $2.2M in export value and 55 verified shipments. Laborate Pharmaceuticals India Limited holds a 7.1% market share in Vati exports across 9 countries. The company exports 13 pharmaceutical products worth $12.2M across 7 therapeutic categories.

Laborate Pharmaceuticals India Limited — Vati Export Profile: Buyers & Destinations

Laborate Pharmaceuticals India Limited Vati export treemap — buyers and destination countries | TransData Nexus

Where Does Laborate Pharmaceuticals India Limited Export Vati?

Country	Value	Shipments	Share
NIGERIA	$1.3M	95	58.4%
KENYA	$484.7K	48	22.4%
TURKEY	$84.6K	22	3.9%
UZBEKISTAN	$80.8K	18	3.7%
AFGHANISTAN	$44.7K

Who Are the Top Buyers of Vati from Laborate Pharmaceuticals India Limited?

Buyer	Country	Value	Orders
EMBASSY PHARMACEUTICAL AND	NIGERIA	$981.3K	84
INVESTMENT & MORTGAGES BANK LTD.	KENYA	$178.6K	34
EMBASSY PHARMACEUTICAL & CHEMICALS	NIGERIA	$163.6K	6
BRITISH PHARMA LTD	UZBEKISTAN	$80.8K	18
TO THE ORDER OF EMBASSY PHARMACEUTI	NIGERIA	$79.9K	3
KAMCARE PHARMA LTD	KENYA	$50.0K	1
ROYAL PHARMA 2011 LTD. (UGANDA)	KENYA	$50.0K	1
TO THE ORDER OF ROYAL PHARMA 2011 L	KENYA	$50.0K	1
ROYAL PHARMA 2011 LTD.	KENYA	$48.4K	1
HEALTHCARE LTD	KENYA	$44.9K	2

Laborate Pharmaceuticals India Limited supplies Vati to 43 buyers globally. The largest buyer is EMBASSY PHARMACEUTICAL AND (NIGERIA), followed by INVESTMENT & MORTGAGES BANK LTD. (KENYA) and EMBASSY PHARMACEUTICAL & CHEMICALS (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vati Formulations Does Laborate Pharmaceuticals India Limited Export?

Product Description / Formulation	Value	Shipments
1-841 EMBASSY VIT B12 INJ. 2ml(Cyanocobalamin USP 1000mcg/ml (as anhydrous), Phenol USP (as preservative) 0.5%w/v) (QTY:	$96.5K	2
1-896 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (AS	$75.5K	4
1-768 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (AS	$66.2K	2
1-300 MALAREST INJECTION 2ML (Quinine Dihydrochloride 300mg/ml, Benzyl Alcohol (as preservative) 2%w/v) BatchNos:OQDIE-0	$50.0K	1
1-2113 DICLOFENAC SODIUM INJ 3ml (Diclofenac Sodium BP 25mg/ml, Benzyl Alcohol BP (as preservative) 4%v/v) (QTY: 42260 B	$50.0K	1
1 740 DICLOFENAC SODIUM INJ 3ml Diclofenac Sodium BP 25mg ml Benzyl Alcohol BP as preservative 4 v v QTY 14800 BO	$50.0K	1
1 673 HYOSCINE INJECTION 1ML Hyoscine Butylbromide BP 10mg ml Chlorobutanol BP as preservative BP 0 5 w v QTY 16152	$50.0K	1
1-576 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (AS	$49.6K	2
1-1400 DICLOFENAC SODIUM INJ 3ml (Diclofenac Sodium BP 25mg/ml, Benzyl Alcohol BP (as preservative) 4%v/v) (QTY: 28000 B	$48.4K	1
1-512 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (ASNOS	$44.0K	6

Laborate Pharmaceuticals India Limited exports 165 distinct Vati formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 1-841 EMBASSY VIT B12 INJ. 2ml(Cyanocobalamin USP 1000mcg/ml with 2 shipments worth $96.5K.

How Does Laborate Pharmaceuticals India Limited Compare to Nearest Vati Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	STERISCIENCE SPECIALTIES PRIVATE LIMITED	$369.7K	18	1	$20.5K
7	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$350.0K	7	3	$50.0K
14	LABORATE PHARMACEUTICALS INDIA LIMITED ★	$339.5K	55	9	$6.2K
13	MICRO LABS LTD	$250.0K	5	2	$50.0K
15	WOCKHARDT LIMITED	$150.0K	3	2	$50.0K

Laborate Pharmaceuticals India Limited ranks #14 among 427 Indian Vati exporters. Average shipment value of $6.2K compared to the market average of $38.3K. The closest competitors by value are STERISCIENCE SPECIALTIES PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Vati Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	1,284	22.4%
DELHI AIR	1,026	17.9%
SAHAR AIR	379	6.6%
SAHAR AIR CARGO ACC (INBOM4)	306	5.3%
NHAVA SHEVA SEA (INNSA1)	179	3.1%
PATLI ICD	171	3.0%
Delhi Air	170	3.0%
Delhi Air Cargo	141	2.5%

Geopolitical & Trade Policy Impact on Laborate Pharmaceuticals India Limited's Vati Exports

Laborate's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions pose challenges for timely delivery of pharmaceutical products, particularly to markets in West Asia and North Africa, which accounted for $1.75 billion of India's pharmaceutical exports in FY 2024–25. (pharmaceuticalcommerce.com)

Conversely, US-China trade tensions have opened opportunities for Indian pharmaceutical exporters. The United States, seeking to diversify its supply chains, has increasingly turned to India, which now supplies 40% of the US's generic drug needs. (business-standard.com) Laborate's EU-GMP certification further enhances its credibility in regulated markets, positioning the company to benefit from these shifts.

However, compliance with the European Union's Falsified Medicines Directive (FMD) presents additional regulatory challenges. The directive mandates stringent serialization and traceability requirements, necessitating investments in technology and process adjustments. Laborate's recent certification indicates a proactive approach to meeting these standards, facilitating smoother access to European markets.

Laborate Pharmaceuticals India Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. India has responded by enhancing compliance, evidenced by a 50% reduction in US FDA Official Action Indicated instances over the past decade. (business-standard.com)

Laborate's attainment of EU-GMP certification for its Paonta Sahib facility underscores its commitment to quality and regulatory compliance. This certification not only facilitates entry into European markets but also serves as a benchmark for other regulatory approvals, including those from the Gulf Cooperation Council (GCC) and the Eurasian Economic Union (EAEU). (pharmaindustrial-india.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vati shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Laborate Pharmaceuticals India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 270 individual customs records matching Laborate Pharmaceuticals India Limited exporting Vati, covering 165 formulations to 18 countries via 43 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 141+ countries, 869+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vati

Vati

Laborate Pharmaceuticals India Limited — Vati Exporter Profile

Laborate Pharmaceuticals India Limited — Vati Export Profile: Buyers & Destinations

Where Does Laborate Pharmaceuticals India Limited Export Vati?

Who Are the Top Buyers of Vati from Laborate Pharmaceuticals India Limited?

What Is India's Total Vati Export Value and How Much Does Laborate Pharmaceuticals India Limited Contribute?

What Is the Average Shipment Value for Laborate Pharmaceuticals India Limited's Vati Exports?

How Does Laborate Pharmaceuticals India Limited Compare to Other Indian Vati Exporters?

What Vati Formulations Does Laborate Pharmaceuticals India Limited Export?

Regulatory Requirements: Exporting Vati to Key Markets

Nigeria — NAFDAC

How Does Laborate Pharmaceuticals India Limited Compare to Nearest Vati Exporters?

Which Indian Ports Ship Vati Exports?

Geopolitical & Trade Policy Impact on Laborate Pharmaceuticals India Limited's Vati Exports

Laborate Pharmaceuticals India Limited — Regulatory Compliance & Quality Standards

About Laborate Pharmaceuticals India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vati Export Data from Laborate Pharmaceuticals India Limited

Vati Stats

Company Overview

Top Products by Laborate Pharmaceuticals India Limited

Related Analysis

Need Detailed Export Data?

Data Source